valley earn sale amgen drug lift incom 3 9 million amgen thousand oak base biotechnolog firm make pharmaceut product report net incom surg 3 9 million fiscal second quarter end septemb 30 12 time 320 000 net incom year earlier revenu doubl 42 5 million 21 5 million gordon blinder amgen chief execut offic said strong third quarter result reflect rise demand compani drug treat anemia kidney dialysi patient drug epogen receiv licens june purchas 95 dialysi center countri blinder said six month end septemb amgen earn 4 7 million seven time 625 000 net incom year earlier revenu total 72 6 million 77 gain 41 million